Limited risk
Testosterone treatment does not increase risk of heart attack
Men taking testosterone therapy are at no greater risk of heart attack during their first year of treatment.
Stories tagged with 'Cardiovascular'
Antibody clues
New antibody can unlock secrets of cholesterol
Researchers at the NHLI have created a monoclonal antibody that could help doctors to spot dangerous plaques in arteries earlier.
News in brief
Making cancer vulnerable and building bridges with MPs: News from the College
Here’s a batch of fresh news and announcements from across Imperial.
COVID-19 symptoms
COVID-19 mapper reveals symptom variation between countries and health status
Imperial research has unveiled how COVID-19 symptoms varied between country and health condition in 2020 in partnership with symptom mapper Healthily.
Cholesterol inequities
First global analysis of rare high cholesterol disorder shows vast disparities
Homozygous Familial Hypercholesterolaemia is often diagnosed late and is under-treated, causing hotspots of cardiovascular disease risk worldwide.
Promising AI tool
Artificial Intelligence tool could help GPs diagnose heart failure
AI can help to improve the performance of ‘smart stethoscopes’, enabling doctors to diagnose heart failure earlier and improving patient outcomes.
Injury legacy
British veterans with combat injuries at greater risk of cardiovascular disease
British soldiers injured in Afghanistan may have a higher risk of heart disease and stroke, compared to their uninjured colleagues.
Valve formation
Bioengineers find new way heart valves grow – and go wrong
Imperial bioengineers have discovered a new mechanism driving the growth of heart valves in zebrafish embryos.
Fasting benefits
Fasting during Ramadan may lower blood pressure – at least temporarily
Fasting during Ramadan is safe and may lower blood pressure – at least temporarily – for both healthy people and those with hypertension.
World Heart Day
World Heart Day: How our cardiovascular scientists are tackling heart disease
The 29 September is World Heart Day, providing the perfect opportunity to reflect on the work of NHLI’s cardiovascular researchers.
